Akebia Therapeutics Stock Forecast

Buy or Hold candidate since Apr 22, 2025 Gain 71.96%

The Akebia Therapeutics stock price gained 3.37% on the last trading day (Friday, 20th Jun 2025), rising from $3.56 to $3.68. During the last trading day the stock fluctuated 4.69% from a day low at $3.52 to a day high of $3.69. The price has risen in 6 of the last 10 days but is still down by -0.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $34.28 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 99.66% during the next 3 months and, with a 90% probability hold a price between $6.40 and $8.55 at the end of this 3-month period.

AKBA Signals & Forecast

The Akebia Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.59 and $3.04. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 06, 2025, and so far it has fallen -7.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Akebia Therapeutics stock

Akebia Therapeutics finds support from accumulated volume at $3.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.165 between high and low, or 4.69%. For the last week, the stock has had daily average volatility of 4.37%.

Our recommended stop-loss: $3.49 (-5.29%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (AKBA) For The Upcoming Trading Day Of Monday 23rd

For the upcoming trading day on Monday, 23rd we expect Akebia Therapeutics to open at $3.63, and during the day (based on 14 day Average True Range), to move between $3.47 and $3.89, which gives a possible trading interval of +/-$0.206 (+/-5.59%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 11.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.64 (1.09%) than the resistance at $3.83 (4.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akebia Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 3.646 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2025 - $3.63 ( 1.40%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*